GlassScriptPhysician profile
Giuseppe Amore
NPI 1245686732
$4,468.64
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.01 · 2020: $162 · 2021: $869 · 2022: $1,987 · 2023: $73.97 · 2024: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,117 · Food and Beverage: $315.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,117.09 |
| Food and Beverage | $315.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,400.72 | 2021-2024 | Octrode, Eterna, Proclaim |
| Medtronic, INC. | $1,348.35 | 2021-2024 | Intellis Adaptivestim |
| Nevro Corp. | $361.17 | 2020-2022 | |
| Boston Scientific Corporation | $141.69 | 2021-2022 | |
| Medtronic USA, INC. | $39.60 | 2020 | |
| Spr Therapeutics, INC | $26.58 | 2020 | |
| Upsher-Smith Laboratories LLC | $26.02 | 2020 | |
| Stimwave Technologies Incorporated | $23.14 | 2022 | |
| Merz North America, INC. | $19.01 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.09 | 2021 | |
| Horizon Therapeutics Plc | $13.53 | 2022 | |
| Biodelivery Sciences International, INC. | $13.33 | 2020 | |
| Tersera Therapeutics LLC | $13.28 | 2020 | |
| Scilex Pharmaceuticals INC. | $13.22 | 2021 | |
| Arbor Pharmaceuticals, INC. | $11.91 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giuseppe Amore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.